Archive for the ‘Bartonella’ Category

Paralyzed by Lyme, They Were Helped With Combo Treatments

https://www.lymedisease.org/remission-from-lyme-paralysis/

Paralyzed by Lyme, they were helped with combo treatments

By Lonnie Marcum

July 19, 2023

A new study from France looks at the use of combination antibiotics and anti-parasitic treatments in patients with limb paralysis as a result of tick-borne infections, including Lyme disease.

Approximately 70% of the patients in this study showed complete remission of symptoms after long-term treatment—a statistic that lines up with the MyLymeData treatment study.

The paper entitled, Complete Remission in Paralytic Late Tick-Borne Neurological Disease Comprising Mixed Involvement of Borrelia, Babesia, Anaplasma, and Bartonella: Use of Long-Term Treatments with Antibiotics and Antiparasitics in a Series of 10 Cases was published in Antibiotics.

The inclusion criteria for this study required a score of 4 or more on the Kurtzke EDSS disability scale; positive blood tests for one or more tick-borne pathogen (including Borrelia burgdorferi, Babesia, Anaplasma or Bartonella); and chronic general symptoms including fatigue, pain, and cognitive deficits lasting six or more months.

The Extended Disability Status Scale (EDSS) is a tool commonly used to quantify the level of disability in patients with multiple sclerosis. The EDSS grades six bodily functions, including visual, brain, bowel/bladder and sensory functions, as well as the patients’ ability to walk and take care of themselves.

All 10 of the patients that qualified for this study were severely disabled with partial or complete paralysis in at least one limb. Five of the 10 required a wheelchair for mobility, and four required assistive devices like walking sticks to get around.

Complete remission for 7 out of 10

Following extended treatment, seven out of 10 patients (70%) showed complete remission of symptoms. Among the nine patients with positive Borrelia serology (along with co-infections), 77% obtained complete remission.

The treatment administered varied according to the patient’s infection profile. The majority of the patients received repeated oral regimens of azithromycin-doxycycline and azithromycin-doxycycline-rifampin plus a minimum of three 35-day cycles of IV ceftriaxone. The eight patients co-infected with Babesia (a parasite) were also administered anti-parasitic cycles of atovaquone–azithromycin. The mean duration of treatment was 20 months +/- 6 months. (Trouillas 2023)

Historically, patients with late-stage Lyme disease have poor outcomes to single regimens of 10-day IV ceftriaxone. (I’ve previously written about brain inflammation, and small fiber neuropathy found in patients with continuing symptoms after short-term treatment for Lyme disease.)

And we have decades of strong evidence that under-treatment with single antibiotics is consistent with persistent infection in animal studies. (Embers 2012)

Two weeks isn’t enough

As far back as 1990, Dr. Allen Steere co-authored a paper on patients with persistent late-stage neurological Lyme disease.

In this paper Dr. Steere and his co-authors state:

Months to years after the initial infection with B. burgdorferi, patients with Lyme disease may have chronic encephalopathy, polyneuropathy, or less commonly, leukoencephalitis. These chronic neurologic abnormalities usually improve with antibiotic therapy.
…
Six months after a two-week course of intravenous ceftriaxone (2 g daily), 17 patients (63 percent) had improvement, 6 (22 percent) had improvement but then relapsed, and 4 (15 percent) had no change in their condition.
…
Six months after treatment, more than one third of the patients either had relapsed or were no better. In addition, more than half had previously received antibiotic therapy thought to be appropriate for their stage of disease and still had progression of the illness. The likely reason for relapse is failure to eradicate the spirochete completely with a two-week course of intravenous ceftriaxone therapy. (Logigian 1990)

MyLymeData

In fact, the MyLymeData study validates that longer antibiotic treatment durations are associated with moderate to a very great deal of improvement. (Johnson 2020)

MyLymeData is currently the largest observational study of patients using real-world data to analyze the response to treatment of chronic Lyme disease patients. The majority of patients (57%) reported treatment durations of four or more months,

The results of this new French study demonstrate the importance of clinicians being able to continue treatment until a patient’s symptoms have resolved. It is clear, at least in this study, that the presence of co-infections greatly compounds one’s disease progress and treatment options.

LymeSci is written by Lonnie Marcum, a Licensed Physical Therapist and mother of a daughter with Lyme. She served two terms on a subcommittee of the federal Tick-Borne Disease Working Group. Follow her on Twitter: @LonnieRhea  Email her at: lmarcum@lymedisease.org.

References

Embers ME, Barthold SW, Borda JT, Bowers L, Doyle L, Hodzic E, et al. Persistence of Borrelia burgdorferi in Rhesus Macaques following Antibiotic Treatment of Disseminated Infection. PLoS ONE. 2012;7(1):e29914. Available at: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0029914.

 Johnson, L.; Shapiro, M.; Stricker, R.B.; Vendrow, J.; Haddock, J.; Needell, D. Antibiotic Treatment Response in Chronic Lyme Disease: Why Do Some Patients Improve While Others Do Not? Healthcare 2020, 8, 383. https://www.mdpi.com/2227-9032/8/4/383

Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med. 1990 Nov 22;323(21):1438-44. doi: 10.1056/NEJM199011223232102. PMID: 2172819.

Trouillas P, Franck M. Complete Remission in Paralytic Late Tick-Borne Neurological Disease Comprising Mixed Involvement of Borrelia, Babesia, Anaplasma, and Bartonella: Use of Long-Term Treatments with Antibiotics and Antiparasitics in a Series of 10 Cases. Antibiotics. 2023; 12(6):1021. https://doi.org/10.3390/antibiotics12061021

_________________

For more:

Category:

Anaplasmosis, Babesia, Bartonella, Lyme, research, Treatment

Best Lab Test for Lyme, Bartonella, & Babesia

https://www.treatlyme.net/guide/best-lab-test-for-borrelia-bartonella-babesia  Video Here (Approx. 8 Min)

Immunoblot is Best Test for Lyme, Bartonella, and Babesia—Here is Why

By Dr. Marty Ross

This video article on testing has two parts.

  • First, I review the differences between IGenex Immunoblot and Armin or Infectolab Americas Elispot testing for the big three tick-borne infections of Borrelia (Lyme), Babesia and Bartonella.
  • The last section of the video compares IGenex Immunoblot and Galaxy Labs PCR tests for Bartonella.

There is clarifying information below the video. Here you can find more information about the meaning of sensitivity and specificity. I also identify the different strains IGenex detects versus the more limited strains Armin or Infectolab Americas detects. Finally, I explain why I do not use Vibrant Labs or DNA Connexions testing.

Terms and Definitions for Tests

To help understand when to use a test or the meaning of a result physicians consider the test sensitivity and specificity.

  • Sensitivity is the ability of a test to find an illness in all people with the illness.
  • Specificity is the ability of a test to correctly identify people without an illness from all people who do not have the illness.

IGenex Immunoblots are Best Because They are Most Sensitive and Specific

IGenex Immunoblot testing is more sensitive for Borrelia, Babesia, and Bartonella testing than Armin and Infectolab Elispot testing because it looks for reactions to more strains of each infection.

  • Borrelia. The test detects antibodies against eight strains including B. afzelii, B. garinii, and B. burgdorferi.
  • Bartonella. The test detects antibodies against the family of Bartonella which includes 15 types thought to infect humans. In addition, it detects specific antibodies against four specific strains named B. henselae, B. vinsonii, B. elizabethae, and B. quintana.
  • Babesia. The test detects antibodies against the family of Babesia which includes B. odecoilei. It also detects specific antibodies against two specific strains named B. microti, and B. duncani.

(See link for article and video)

________________

For more:

Category:

Babesia, Bartonella, Lyme, Testing

Unraveling Bartonella: Dr. Mozayeni

https://www.betterhealthguy.com/episode185

Episode #185: Unraveling Bartonella with Dr. B. Robert Mozayeni, MD

 
 
About My Guest

My guest for this episode is Dr. B. Robert Mozayeni.  B. Robert Mozayeni, MD is an expert in Translational Medicine, the science and art of advancing medical science safely and efficiently.  He is the Chief Medical Officer of Galaxy Diagnostics, LLC.  He is a co-founder of the Foundation for the Study of Inflammatory Diseases.  He serves as an advisor to pharmaceutical and nutraceutical companies and serves on an Institutional Review Board specializing in nutraceutical products for pain management.  He is the immediate past President of ILADS, the International Lyme and Associated Diseases Society where his goal was to advance the science of translational medicine.  In late 2019, Dr. Mozayeni launched T Lab Inc., a research and clinical laboratory engaged in research using advanced microscopy to understand better the pathogenesis of disease in inflammatory conditions associated with persistent infections.  He has research and clinical expertise with regard to autoimmune diseases and the effects of chronic infection and inflammation on vascular physiology and neurovascular conditions seen commonly with autoimmune and neurovascular diseases.  With a strong foundation in the basic sciences and evidence-based medicine, he analyzes complex medical cases using a combination of basic scientific principles and clinical experience along with the balance of the evidence base.  Dr. Mozayeni has published numerous papers on immunology and cerebrovascular blood flow hemodynamics.  He has been actively researching and publishing his work on chronic rheumatic diseases and their relationship to persistent human Bartonella spp. infection.  Of note, chronic persistent Bartonella spp. infections are strongly associated with neurovascular diseases.  Thus, Dr. Mozayeni is uniquely qualified in the combined areas of chronic persistent endovascular infections and related rheumatological and neurovascular diseases.   He has also published papers providing new insights as to a potential infectious  (Bartonella spp.) cause of osteoarthritis and also, a case of arthritis associated with hypermobility that was likely caused by Bartonella spp.

Key Takeaways
  • What advances have been observed in recent years in the realm of Bartonella?
  • What are common symptoms of Bartonella?
  • How is Bartonella transmitted?- Might Bartonella lead to autoimmunity?
  • Can Bartonella be a trigger for PANS?
  • Might Bartonella be a contributor to osteoarthritis?
  • Is there a connection between Bartonella and hypermobility or EDS?
  • Does Bartonella contribute to MS?
  • What is the connection between Bartonella and SIBO?
  • Can Bartonella act as a trigger for MCAS?
  • Is Bartonella activation observed in those with COVID?
  • What is the state of the art in Bartonella testing?
  • What is Babesia odocoilei?
  • What agents are most helpful in the treatment of Bartonella?
  • Is there a place for herbs and other natural interventions in Bartonella treatment?
  • Should pets be considered as a potential source of exposure to Bartonella?
Connect With My Guest

http://TMGMD.com

Related Resources

Article: Unraveling the Mystery of Bartonellosis

Transcript

Go to top link for transcript, video, and audio

For more:

Category:

Bartonella, Cancer, Eye Issues, Heart Issues, Inflammation, Psychological Aspects

Relocated Cats & Disseminated Vector-Borne & Other Pathogens of Potential Relevance

https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-022-05553-8

Vector-borne and other pathogens of potential relevance disseminated by relocated cats

Parasites & Vectors volume 15, Article number: 415 (2022) Cite this article

Abstract

Large populations of unowned cats constitute an animal welfare, ecological, societal and public health issue worldwide. Their relocation and homing are currently carried out in many parts of the world with the intention of relieving suffering and social problems, while contributing to ethical and humane population control in these cat populations. An understanding of an individual cat’s lifestyle and disease status by veterinary team professionals and those working with cat charities can help to prevent severe cat stress and the spread of feline pathogens, especially vector-borne pathogens, which can be overlooked in cats. In this article, we discuss the issue of relocation and homing of unowned cats from a global perspective. We also review zoonotic and non-zoonotic infectious agents of cats and give a list of practical recommendations for veterinary team professionals dealing with homing cats. Finally, we present a consensus statement consolidated at the 15th Symposium of the Companion Vector-Borne Diseases (CVBD) World Forum in 2020, ultimately to help veterinary team professionals understand the problem and the role they have in helping to prevent and manage vector-borne and other pathogens in relocated cats.  (See link for article)

__________________

For more:

Category:

Activism, Bartonella, research, Toxoplasmosis, Transmission

A Child Can No Longer Walk. Before COVID, There Was Lyme Disease Denial

https://rescue.substack.com/p/a-child-can-no-longer-walk-before

A Child Can No Longer Walk. Before Covid, There Was Lyme Disease Denial.

Lyme disease left her paralyzed at 11. Now 19, the girl blessed by the Pope is suing doctors who refused to treat.

MARY BETH PFEIFFER
APR 29, 2023
Julia Bruzzese, now 19, whose Lyme disease went undiagnosed and untreated for nearly two years, causing paraplegia at age 11. A medical malpractice lawsuit has been filed in New York City on her behalf.

This is a story of medical ignorance: How an infection was allowed to fester even when safe, generic drugs could have stopped it.

No, this is not about covid-19. This is a story of Lyme disease.

Before a pandemic came along, Lyme disease was among the most controversial and, in late stages, abysmally treated infection in medicine.

As covid wanes, the tick-borne illness is still all those things. That is why a nineteen-year-old woman, who represents chronic Lyme sufferers worldwide, is suing a dozen doctors, a pediatric practice, and three hospitals in New York City for medical malpractice.

If anybody can change the image and practice of Lyme disease, it is Julia Rose Bruzzese of Brooklyn, the girl in a wheelchair who met the Pope on an airport tarmac at the age of twelve in hope of a miracle. Maybe, just maybe, she will get it.

First, her odyssey.  (See link for article)

SUMMARY:

  • Julia had a glaring EM rash the doctors simply ignored.
  • This error of ignorance was repeated over two more years and she was accused of making it all up.
  • When her dad suggested it might be tick-borne illness he was treated like he was using profanity.
  • Julia’s lawsuit contends that the continued refusal of doctors and hospitals resulted in her life in a wheelchair and she is seeking judgement and financial damages that would be fair, adequate and just.
  • Her father has fought battles for Julia before when attempting a medical insurance appeal.
  • Author of the article, Mary Beth Pfeiffer, has interviewed scores of others with similar stories of Lyme ruin and denial.
  • Due to this medical controversy another group of doctors has formed the International Lyme and Associated Diseases Society (ILADS) which faults the IDSA for using low-quality and flawed evidence behind their entire paradigm.
    • This group still insists upon using a 30 year old diagnostic test that is wrong some 40% of the time with early infection and anywhere from 70–86% in late infection.  Yet this test is followed like the Rosetta Stone.
    • This group also recommends longer prophylactic antibiotics after tick bites and initial infection, and retreatment for persisting symptoms.  Due to this approach, Julia finally felt her feet for the first time in months.
  • Julia experienced extremely abusive situations by doctors throughout this journey including gas-lighting, taking away her wheelchair to see if she would get up to use the bathroom, poking prods into her lifeless legs when she slept, waking up to a large group of doctors looking down on her to observe a supposed case of “conversion disorder,” being dragged along a hospital hallway, and taking all her weight but then dropping her despite her cries of pain.
  • The family has had financial troubles due to this.
  • Julia has faced frightening litany of symptoms that have progressed and worsened over time due to lack of treatment. She has had GBS, POTS, distended bladder, cognitive impairment, vision and hearing difficulties, insomnia, atrophy, migratory joint pain, encephalitis, seizures, severe fatigue, osteopenia, and many other problems.
  • The defendants have denied all claims in the lawsuit, filed in March 2021.
  • Julia made global news when she sought a blessing from the Pope in 2015.
  • Finally able to obtain testing, she now had evidence of 5 infections: Lyme, Babesia, Tularemia, and Bartonella and received treatment which helped but did not cure her long-ignored condition.
  • Julia’s story is now chronicled in a critically acclaimed documentary that is now screening around the country.
  • The ignorance being experienced is largely to a one-size-fits-all medical model which is a huge ongoing problem.
  • While Julia’s lawsuit is a year or more from trial, another trial is coming in May for a “wrongful death” in a young man who had a negative test but ended up dying from Lyme carditis.  A case report in Cardiovascular Pathology journal two years later documented the damage to his heart. There, in color, were corkscrew-shaped Borrelia burgdorferi spirochetes, the causative agent of Lyme disease. Similarly to Julia, he was not treated with a round of antibiotics that likely would have spared him.  Journal articles continue to minimize the severity of tick-borne illness by insisting that they are self-limiting conditions.  Therefore, doctors are lazy and apathetic toward a complex illness that has and will kill or maim a good number of patients.
  • A false narrative also continues to insist that people are over diagnosed with Lyme due to supposed false positive tests.
  • Despite stories like this (and thousands more) nothing has changed in Lymeland. 
  • What’s the answer?  Good question.  Pfeiffer thinks maybe big money payouts will help our plight. Recently a Maine lawsuit awarded a family 6.5 million from a hospital and doctor in the Lyme carditis death of a twenty-five-year-old man in 2017.
    • The lawyer who won the case is the same lawyer in Julia’s case as well as in the other Lyme carditis death.  He has yet to earn a dime.  How many lawyers will fight for sick Lyme patients without a living wage?  Food for thought.
  • Like all good dads, Julia’s father is worried for her future, but Julia’s greatest weapon continues to be her optimism.  She is in pre-med, paints, crochets, bakes, and is a make-up artist.

Category:

Activism, Babesia, Bartonella, Lyme, Tularemia